Skip to main content
Signal8
Moses Jennifer K. profile photo

Jennifer K. Moses

CIK: 0001706667

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)2 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

Viridian Therapeutics, Inc.\DE logo
VRDN

Viridian Therapeutics, Inc.\DE

Director

Discretionary Trading P&L

Holdings

Transaction History (2 total)

  • Viridian Therapeutics, Inc.\DE logo
    VRDN

    Viridian Therapeutics, Inc.\DE

    Jul 1, 2026
    Award(A)

    Stock Option (Right to Buy)

    Direct
    32.3K shares-
  • Viridian Therapeutics, Inc.\DE logo
    VRDN

    Viridian Therapeutics, Inc.\DE

    Jul 1, 2025
    Award(A)

    Stock Option (Right to Buy)

    Direct
    21K shares-

1-2 of 2

About Moses Jennifer K.

Moses Jennifer K. (SEC CIK 0001706667) files insider reports with the SEC as Director of Viridian Therapeutics, Inc.\DE (VRDN).

Signal8 holds 2 ownership filings by Moses Jennifer K., all Form 4s, filed between Jul 2, 2025 and Jul 2, 2026. Those filings report 2 transactions, from Jul 1, 2025 to Jul 1, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Moses Jennifer K.'s filings is in WALTHAM, MA.

Recent filings by Moses Jennifer K.

  • Jul 1, 2026: Grant or award of VRDN derivative securities (Form 4, code A).
  • Jul 1, 2025: Grant or award of VRDN derivative securities (Form 4, code A).

Other insiders filing for Viridian Therapeutics, Inc.\DE (VRDN)

How to read Form 4 transaction codes